Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial
Abstract: Hepatic toxicity is the most serious adverse effect of anti-tuberculosis drugs. This study was performed to evaluate the efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial, 70 new cases of pulmonary tuberculosis were divided into two grou...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Shaheed Beheshti University of Medical Sciences
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986122/ |